Home|Journals|Articles by Year|Audio Abstracts
 

8 articles found.


Publishing Year(s)



Click to Change Year(s)

Journal(s)



Click to Change Journal(s)
  1. The Analgesic Effect of a Curcumin Analogue 1,5-bis(4’-hydroxy-3’-methoxyphenyl)-1,4-pentadien-3-on (Gamavuton-0) in acute and persistent pain
    Zullies Ikawati, Nunung Yuniarti, Supardjan Amir Margono
    Journal of Applied Pharmaceutical Science. 2014; 4(8): 048-051.
  2. ACUTE TOXICITY AND SUPPRESSIVE EFFECTS OF A CURCUMIN ANALOGUE GAMAVUTON-0 (GVT-0) ON CFA-INDUCED ARTHRITIS IN RATS
    Zullies Ikawati, Nunung Yuniarti, Supardjan Amir Margono
    Journal of Applied Pharmaceutical Science. 2014; 4(11): 019-023.
  3. Effect of Curcuma longa L. extract on noninvasive cardiovascular biomarkers in hypertension animal models
    Patonah Hasimun, Agus Sulaeman, Arif Hidayatullah, Yani Mulyani
    Journal of Applied Pharmaceutical Science. 2021; 11(8): 85-89.
  4. The relationship between medication errors in prescribing phase and service quality on national health insurance patients of pharmacy unit in public hospital in Bandung city
    Norisca Aliza Putriana, Nunung Nurjanah, Angga Prawira Kautsar
    National Journal of Physiology, Pharmacy and Pharmacology. 2018; 8(4): 585-589.
  5. Diagnosis and treatment of urolithiasis in a Toy Poodle dog
    Guntari Titik Mulyani, Agung Budi Pramono , Tri Wahyu Pangestiningsih
    Open Veterinary Journal. 2024; 14(3): 937-940.


Online Article Submission
• ejmanager.com


ejPort - eJManager.com
Refer & Earn
JournalList
 About BiblioMed
License Information
Terms & Conditions
Privacy Policy
 Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.